oxazoles has been researched along with Carcinoma, Squamous Cell in 13 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (15.38) | 18.7374 |
1990's | 3 (23.08) | 18.2507 |
2000's | 5 (38.46) | 29.6817 |
2010's | 3 (23.08) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Asik, A; Biray Avcı, C; Dogan, F; Gasimli, R; Gunduz, C; Kayabasi, C; Ozmen Yelken, B; Sogutlu, F; Yilmaz Süslüer, S | 1 |
Cao, HH; Chen, B; Chen, H; Du, ZP; Huang, W; Jia, W; Jiang, H; Li, EM; Li, LY; Liao, LD; Xie, JJ; Xie, YM; Xu, LY; Xu, XE; Zeng, FM; Zhang, YL; Zheng, W | 1 |
Ahmed, A; Atula, T; Haglund, C; Hagström, J; Lehtonen, S; Mäkinen, LK; Mäkitie, AA; Salo, T | 1 |
Bergs, JW; Buist, MR; Darroudi, F; Franken, NA; Haveman, J; Jaarsma, PA; Medema, JP; Rodermond, HM; Stalpers, LJ; Ten Cate, R; Van Bree, C | 1 |
Liu, XH; Lv, PC; Song, BA; Xue, JY; Zhu, HL | 1 |
Balm, A; Begg, AC; Martin, JM; Sprong, D | 1 |
Alekseenko, VA; Gusev, KO; Kaznacheeva, EV | 1 |
Bai, R; Dettin, LE; Glazer, RI; Kopelovich, L; Kopleovich, L; Kozikowski, AP; Russell, RG; Wei, ZL; Yin, Y | 1 |
Hosoi, K; Kurihara, K; Ueha, T | 1 |
Kawakami, K; Mizuno, H; Nishimura, G; Tsukuda, M; Yanoma, S | 1 |
Fujita, M; Fukuda, J; Haneji, T; Kobayashi, S; Seta, C | 1 |
Bergeron, R; Honeysett, JM; Taetle, R | 1 |
Blessing, JA; Buchsbaum, HJ; DiSaia, PJ; McGuire, WP | 1 |
13 other study(ies) available for oxazoles and Carcinoma, Squamous Cell
Article | Year |
---|---|
The effect of ICRT-3 on Wnt signaling pathway in head and neck cancer.
Topics: Apoptosis; beta Catenin; Carcinoma, Squamous Cell; Caspase 3; Caspase 9; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Movement; Cell Survival; Cytotoxins; Gene Expression Regulation, Neoplastic; Head and Neck Neoplasms; Humans; Hypopharyngeal Neoplasms; Inhibitory Concentration 50; Lymphoid Enhancer-Binding Factor 1; Neoplastic Stem Cells; Oxazoles; Signal Transduction; Transcription Factor 4; Wnt Signaling Pathway | 2019 |
Macrolide analog F806 suppresses esophageal squamous cell carcinoma (ESCC) by blocking β1 integrin activation.
Topics: Animals; Antineoplastic Agents; Apoptosis; Carcinoma, Squamous Cell; Cell Adhesion; Cell Line, Tumor; Cell Proliferation; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Humans; Integrin beta1; Male; Mice; Mice, Nude; Oxazoles; Random Allocation; Xenograft Model Antitumor Assays | 2015 |
Toll-like receptors 2, 4, and 9 in primary, metastasized, and recurrent oral tongue squamous cell carcinomas.
Topics: Acetates; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Cell Line, Tumor; Female; Head and Neck Neoplasms; Humans; Immunohistochemistry; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Oxazoles; Squamous Cell Carcinoma of Head and Neck; Toll-Like Receptor 2; Toll-Like Receptor 4; Toll-Like Receptor 9; Toll-Like Receptors; Tongue Neoplasms | 2016 |
Transient inhibition of Calyculin A induced premature chromosome condensation by hyperthermia.
Topics: Carcinoma, Squamous Cell; CDC2 Protein Kinase; Cell Line, Tumor; Chromatin Assembly and Disassembly; Chromosome Aberrations; Cyclin B; Cyclin B1; Cyclin-Dependent Kinases; Female; Fever; Histones; Humans; Hyperthermia, Induced; Lung Neoplasms; Marine Toxins; Oxazoles; Phosphorylation; Uterine Cervical Neoplasms | 2009 |
Novel 2,4,5-trisubstituted oxazole derivatives: synthesis and antiproliferative activity.
Topics: Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Drug Screening Assays, Antitumor; Humans; Inhibitory Concentration 50; Male; Oxazoles; Prostatic Neoplasms; Structure-Activity Relationship | 2009 |
Premature chromosome condensation and cell separation studies in biopsies from head and neck tumors for radiosensitivity prediction.
Topics: Adenocarcinoma; Carcinoma, Squamous Cell; Cell Cycle; Cell Division; Cell Separation; Chromosome Aberrations; Fibroblasts; Flow Cytometry; Head and Neck Neoplasms; Humans; Marine Toxins; Oxazoles; Radiation Tolerance; Tumor Cells, Cultured | 2002 |
[Effects of actin cytoskeleton rearrangements on channel activation by calcium entry into A431 cells].
Topics: Actins; Calcium; Calcium Channel Agonists; Calcium Channels; Calcium Signaling; Carcinoma, Squamous Cell; Cell Line; Cell Membrane; Cytochalasin D; Cytoskeleton; Electric Conductivity; Extracellular Space; Humans; Inositol 1,4,5-Trisphosphate; Ion Channel Gating; Marine Toxins; Oxazoles; Patch-Clamp Techniques; Thapsigargin; Tumor Cells, Cultured | 2003 |
Peroxisome proliferator-activated receptor delta and gamma agonists differentially alter tumor differentiation and progression during mammary carcinogenesis.
Topics: Animals; Anticarcinogenic Agents; Carcinoma, Adenosquamous; Carcinoma, Ductal; Carcinoma, Squamous Cell; Cell Differentiation; Disease Progression; Female; Gene Expression Profiling; Mammary Neoplasms, Experimental; Mice; Oxazoles; PPAR delta; PPAR gamma; Thiazoles; Tyrosine | 2005 |
Bradykinin-stimulated transient modulation of epidermal growth factor receptors in A-431 human epidermoid carcinoma cells.
Topics: Alkaloids; Binding, Competitive; Bradykinin; Carcinoma, Squamous Cell; ErbB Receptors; Humans; Marine Toxins; Oxazoles; Phosphoprotein Phosphatases; Phosphorylation; Protein Kinase C; Staurosporine; Tumor Cells, Cultured | 1993 |
A selective cyclooxygenase-2 inhibitor suppresses tumor growth in nude mouse xenografted with human head and neck squamous carcinoma cells.
Topics: Animals; Benzenesulfonates; Carcinoma, Squamous Cell; Cell Cycle; Cell Division; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Cytotoxicity, Immunologic; Female; G1 Phase; Head and Neck Neoplasms; Humans; Isoenzymes; KB Cells; Killer Cells, Lymphokine-Activated; Killer Cells, Natural; Membrane Proteins; Mice; Mice, Nude; Oxazoles; Platelet-Derived Growth Factor; Prostaglandin-Endoperoxide Synthases; Telomerase; Transplantation, Heterologous | 1999 |
Induction of apoptosis in human oral squamous carcinoma cell lines by protein phosphatase inhibitors.
Topics: Apoptosis; Carcinoma, Squamous Cell; Enzyme Inhibitors; Humans; Marine Toxins; Mouth Neoplasms; Okadaic Acid; Oxazoles; Phosphoprotein Phosphatases; Tumor Cells, Cultured | 1999 |
Combination iron depletion therapy.
Topics: Antibodies, Monoclonal; Antineoplastic Agents; Carcinoma, Squamous Cell; Cell Cycle; Cell Division; Chelating Agents; Drug Screening Assays, Antitumor; Female; Gallium; Granulocytes; Hematopoietic Stem Cells; Humans; Immunoglobulin A; Iron Deficiencies; Leukemia, Myeloid; Lymphoma, Large B-Cell, Diffuse; Macrophages; Ovarian Neoplasms; Oxazoles; Receptors, Transferrin; Tumor Cells, Cultured | 1989 |
Phase II trial of acivicin in patients with advanced epithelial ovarian carcinoma. A Gynecologic Oncology Group Study.
Topics: Adult; Antibiotics, Antineoplastic; Carcinoma, Squamous Cell; Dose-Response Relationship, Drug; Drug Evaluation; Female; Hematologic Diseases; Humans; Isoxazoles; Middle Aged; Nervous System Diseases; Ovarian Neoplasms; Oxazoles | 1986 |